Lincoln National Corp Bristol Myers Squibb CO Transaction History

Lincoln National Corp

$3.11 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$47.98 - $54.4 $146,434 - $166,028	3,052 Added 7.66%	42,894 $2.33 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $1.01 Million - $1.2 Million	-20,821 Reduced 34.32%	39,842 $2.04 Million
Q3 2023 Nov 03, 2023	BUY	$57.89 - $64.73 $20,898 - $23,367	361 Added 0.6%	60,663 $3.52 Million
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $224,705 - $249,499	3,527 Added 6.21%	60,302 $3.86 Million
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $1.26 Million - $1.43 Million	19,246 Added 51.28%	56,775 $3.94 Million
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $85,394 - $101,119	1,247 Added 3.44%	37,529 $2.7 Million
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $18 - $10,757	140 Added 0.39%	36,282 $2.58 Million
Q2 2022 Aug 02, 2022	SELL	$72.62 - $79.98 $314,226 - $346,073	-4,327 Reduced 10.69%	36,142 $2.78 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $5,164 - $6,192	84 Added 0.21%	40,469 $2.96 Million
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $215,378 - $251,080	-4,016 Reduced 9.04%	40,385 $2.52 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $125,854 - $147,422	2,127 Added 5.03%	44,401 $2.63 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $129,515 - $141,042	-2,092 Reduced 4.72%	42,274 $2.83 Million
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $4,747 - $5,339	-80 Reduced 0.18%	44,366 $2.8 Million
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $145,504 - $164,883	2,520 Added 6.01%	44,446 $2.76 Million
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $32,964 - $36,529	-574 Reduced 1.35%	41,926 $2.53 Million
Q2 2020 Jul 31, 2020	BUY	$54.82 - $64.09 $102,787 - $120,168	1,875 Added 4.62%	42,500 $2.5 Million
Q1 2020 Apr 24, 2020	BUY	$46.4 - $67.43 $222,116 - $322,787	4,787 Added 13.36%	40,625 $2.27 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $507,158 - $661,542	10,306 Added 40.37%	35,838 $2.3 Million
Q3 2019 Nov 06, 2019	BUY	$42.77 - $50.71 $211,112 - $250,304	4,936 Added 23.97%	25,532 $1.3 Million
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $192,446 - $212,803	4,313 Added 26.49%	20,596 $934,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $102,016 - $121,641	2,261 Added 16.12%	16,283 $777,000
Q4 2018 Feb 08, 2019	BUY	$48.76 - $63.23 $41,055 - $53,239	842 Added 6.39%	14,022 $729,000
Q3 2018 Nov 06, 2018	SELL	$55.19 - $62.25 $55,521 - $62,623	-1,006 Reduced 7.09%	13,180 $818,000
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $23,546 - $29,348	-466 Reduced 3.18%	14,186 $785,000
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $781,836 - $900,051	-13,048 Reduced 47.1%	14,652 $927,000
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $809,909 - $883,009	13,512 Added 95.24%	27,700 $1.7 Million
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $74,505 - $85,985	1,349 Added 10.51%	14,188 $905,000
Q2 2017 Aug 07, 2017	BUY	N/A	12,839	12,839 $716,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Account